|
FAM120A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.559770E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.719600E-01 |
| Normal-vs-Stage2 |
8.278400E-01 |
| Normal-vs-Stage3 |
5.554000E-02 |
| Normal-vs-Stage4 |
2.556400E-03 |
| Stage1-vs-Stage2 |
7.843800E-01 |
| Stage1-vs-Stage3 |
9.939700E-02 |
| Stage1-vs-Stage4 |
8.657800E-03 |
| Stage2-vs-Stage3 |
2.085800E-01 |
| Stage2-vs-Stage4 |
3.337700E-02 |
| Stage3-vs-Stage4 |
2.371400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.428360E-01 |
| Normal-vs-AfricanAmerican |
6.074400E-01 |
| Normal-vs-Asian |
1.318630E-01 |
| Caucasian-vs-AfricanAmerican |
7.370600E-01 |
| Caucasian-vs-Asian |
6.662600E-01 |
| AfricanAmerican-vs-Asian |
5.284200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.800000E-01 |
| Normal-vs-Female |
1.583440E-01 |
| Male-vs-Female |
9.128000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.642800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.304200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.362200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.427620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.208000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.967800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.551200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.326800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.878000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.376800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.978000E-01 |
| Classical-VS-Follicular |
8.130600E-01 |
| Classical-VS-Other |
8.694000E-01 |
| Classical-VS-Normal |
3.451400E-01 |
| Tall-VS-Follicular |
3.067400E-01 |
| Tall-VS-Other |
7.130400E-01 |
| Tall-VS-Normal |
1.048360E-01 |
| Follicular-VS-Other |
8.254800E-01 |
| Follicular-VS-Normal |
5.807800E-01 |
| Other-VS-Normal |
5.658600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.645590E-01 |
| Normal-vs-N1 |
1.266040E-02 |
| N0-vs-N1 |
1.168640E-01 |
|
|
